The Floor · H.R. 383 · Committee
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
No sponsor archived.
No committee referrals archived.
Path through Congress · started in the House
H.R. 383 · 118th
Status
Committee
Introduced
Missing date
Committee
Missing date
House floor
Senate floor
Resolving differences
Enrolled
President's desk
Became law
Latest action · Jan 27, 2023
Referred to the Subcommittee on Health.
No recorded roll calls are listed for this bill. Many measures pass by voice vote or unanimous consent without a member-by-member tally. If Congress.gov later shows recorded votes, they will appear here.
Archive built 2026-09-23 from Library of Congress Congress.gov API.